Insider Purchases: Inside the Buy
Tag: insider buying
🏰 RH (NYSE: RH): Insider Buying, 34% Short Interest, and a Luxury Turnaround Worth Watching
RH isn't just selling luxury furniture anymore—it's trying to redefine luxury living. With a major insider purchase, elevated short interest, ambitious global expansion, and Wall Street split on the outlook, RH may be one of today's most intriguing turnaround stories.
📐 Autodesk (ADSK): Insider Buying, 58% Free Cash Flow Growth, and the AI "AIntegration" Opportunity
Autodesk isn't trying to beat AI—it may be one of the companies best positioned to integrate it. With executives buying shares, free cash flow soaring 58%, and a surprisingly attractive PEG ratio, ADSK deserves another look.
🎨 Adobe (ADBE) Stock Analysis: Why Eli Lilly CEO David Ricks Just Bought $1.9 Million of Adobe Stock
Wall Street says AI threatens Adobe. The numbers tell a different story. Revenue keeps hitting records, AI recurring revenue has tripled, valuation has collapsed to multi-year lows, and Eli Lilly CEO David Ricks just invested another $1.9 million of his own money. Here's why Adobe may deserve another look.
🚗 CarMax (KMX) Stock Analysis: Why the New CEO Just Bought $500K of Stock
CarMax isn't a flashy AI stock—but it may be one of the more interesting turnaround stories in today's market. New CEO Keith Barr just invested nearly $500,000 of his own money, institutions control over 112% of the float, and valuation appears unusually attractive on a PEG basis. Here's why we think investors should take a closer look.
🛰️ The Venture Secondary Discount: Inside Powerlaw's Pre-IPO Liquidity Arbitrage
Powerlaw isn't simply another investment company—it's a gateway into some of the world's most valuable private technology businesses. With insider buying near NAV and holdings including SpaceX, OpenAI, Kalshi, Stripe and Anthropic, investors must answer one key question: are they buying today's NAV, or tomorrow's?
🩺 Abbott Laboratories (ABT) Stock Analysis: Can a Dividend King Turn Exact Sciences Into Its Next Growth Engine?
Abbott Laboratories may not be flashy, but the healthcare giant combines insider buying, a growing oncology diagnostics platform, the dominant FreeStyle Libre franchise, and more than a century of dividend payments. With shares trading near 16x forward earnings, investors may be looking at a classic Growth at a Reasonable Price opportunity.
🥑 Mission Produce (AVO) Stock Analysis: Why Insiders Just Bought $7.9 Million of Stock
Mission Produce's directors recently deployed nearly $7.9 million of personal capital into AVO shares. Combined with the Calavo acquisition, a fresh $100 million buyback, and a move into higher-margin prepared foods, the avocado giant may be entering a new chapter.
💳 Fiserv Insiders Keep Averaging Down. Wall Street Sees Trouble. Bulls See A 6x Earnings Cash Machine.
Fiserv's executives are putting their money where their mouths are. With insider buying surging, Clover processing $324 billion annually, and valuation multiples near historic lows, the payments giant has become one of Wall Street's more fascinating turnarounds.
🎢 Six Flags Entertainment (FUN): The 116% Phantom Float Monopoly, Rehan Jaffer's $5.8M Ride, and the 7-Day Short Burn
Six Flags may be more than a roller coaster stock. Insider buying, season-pass growth, improving EBITDA and an unusual ownership structure make FUN one of the more fascinating turnaround stories in leisure.
🏝️ The 125% Float Monopoly: Inside Oxford Industries' High-Conviction Floor and the 8-Day Island Squeeze
With insiders buying, institutions owning more than the float itself, a 7.5% dividend yield and Tommy Bahama still thriving, Oxford Industries presents one of the more unusual setups in retail.
Quick links
Search
About/Leadership
Editorial Process
Privacy Policy
Refund Policy
Shipping Policy
Terms of Service
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.
